The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 3.10

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 30-34

Both Sexes

Site 1975-2018 2009-2018
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 77,692 88.3 0.8* 20,893 99.9 0.2
1. Leukemias 2,620 3.0 0.8* 713 3.4 0.8*
2. Lymphomas 8,071 9.2 0.9 1,790 8.6 -0.9*
3. CNS, intracranial, intraspinal 3,017 3.4 0.4* 766 3.7 0.4*
4. Osseous & chondromatous neoplasms 573 0.7 0.5 141 0.7 0.5
5. Soft tissue sarcomas 5,603 6.4 1.0 802 3.8 -0.8
6. Germ cell and trophoblastic neoplasms 6,472 7.4 1.7* 1,784 8.5 0.6*
7. Melanoma and skin carcinomas 9,818 11.2 1.4* 2,593 12.4 0.2
8. Carcinomas (excluding skin) 39,827 45.3 0.8* 11,663 55.8 1.9*
9. Miscellaneous specified neoplasms, NOS 1,266 1.4 2.9* 525 2.5 2.1*
10. Unspecified malignant neoplasms 385 0.4 0.7 93 0.4 0.7

Males

Site 1975-2018 2009-2018
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 31,624 71.8 0.7 7,822 74.5 -0.4
1. Leukemias 1,504 3.4 0.7* 396 3.8 0.7*
2. Lymphomas 4,946 11.2 1.0 1,034 9.8 -1.0*
3. CNS, intracranial, intraspinal 1,759 4.0 0.3 446 4.2 0.3
4. Osseous & chondromatous neoplasms 325 0.7 0.7 86 0.8 0.7
5. Soft tissue sarcomas 4,418 10.0 1.1 501 4.8 -1.6*
6. Germ cell and trophoblastic neoplasms 6,061 13.8 1.7* 1,680 16.0 0.6*
7. Melanoma and skin carcinomas 3,849 8.7 0.1 927 8.8 0.1
8. Carcinomas (excluding skin) 8,088 18.4 0.9* 2,490 23.7 2.5*
9. Miscellaneous specified neoplasms, NOS 515 1.2 2.4* 211 2.0 -1.8
10. Unspecified malignant neoplasms 142 0.3 - 41 0.4 -

Females

Site 1975-2018 2009-2018
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 46,068 104.9 0.9* 13,071 125.5 1.4*
1. Leukemias 1,116 2.5 0.8* 317 3.0 0.8*
2. Lymphomas 3,125 7.1 0.6* 756 7.3 -1.7*
3. CNS, intracranial, intraspinal 1,258 2.9 0.5* 320 3.1 0.5*
4. Osseous & chondromatous neoplasms 248 0.6 - 55 0.5 -
5. Soft tissue sarcomas 1,185 2.7 0.2 301 2.9 0.2
6. Germ cell and trophoblastic neoplasms 411 0.9 0.1 104 1.0 0.1
7. Melanoma and skin carcinomas 5,969 13.6 2.0* 1,666 16.0 1.0*
8. Carcinomas (excluding skin) 31,739 72.3 0.8* 9,173 88.0 1.7*
9. Miscellaneous specified neoplasms, NOS 751 1.7 3.0* 314 3.0 5.1*
10. Unspecified malignant neoplasms 243 0.6 - 52 0.5 -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2018.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.